Cargando…
Case Report: tacrolimus toxicity in the setting of concurrent Paxlovid use in a heart-transplant recipient
BACKGROUND: Tacrolimus toxicity in patient’s status post-orthotropic heart transplantation is not commonly reported. Given its narrow therapeutic window and drug–drug interactions, it must be closely monitored by providers who are experienced in transplant management. There are no case series of pat...
Autores principales: | Modi, Sujal, Kahwash, Rami, Kissling, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220502/ https://www.ncbi.nlm.nih.gov/pubmed/37252201 http://dx.doi.org/10.1093/ehjcr/ytad193 |
Ejemplares similares
-
Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022) -
Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient
por: Maynard, Robert D., et al.
Publicado: (2023) -
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
por: Kwon, Eun-Jeong, et al.
Publicado: (2022) -
Risks of paxlovid in a heart transplant recipient
por: Stawiarski, Kristin, et al.
Publicado: (2023) -
Paxlovid-Induced Tacrolimus Toxicity in the Treatment of COVID-19: A Case Report
por: Michael, Stephanie, et al.
Publicado: (2023)